Patent details

EP3377179 Title: DEUTERATED EPI-743

Basic Information

Publication number:
EP3377179
PCT Application Number:
US2016062760
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168672178
PCT Publication Number:
WO2017087795
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DEUTERATED EPI-743
French Title of Invention:
EPI-743 DEUTÉRÉ
German Title of Invention:
DEUTERIERTES EPI-743
SPC Number:

Dates

Filing date:
18/11/2016
Grant date:
07/04/2021
EP Publication Date:
26/09/2018
PCT Publication Date:
26/05/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/04/2021
EP B1 Publication Date:
07/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/11/2021
Expiration date:
18/11/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/03/2021
 
 

Name:
Concert Pharmaceuticals Inc.
Address:
65 Hayden Avenue, Suite 3000N, Lexington, MA 02421, United States (US)

Inventor

1

Name:
WONG, Darren H.
Address:
United States (US)

2

Name:
LIU, Julie F.
Address:
United States (US)

Priority

Priority Number:
201562257567 P
Priority Date:
19/11/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/045; A61P 39/06; C07B 59/00;

Publication

European Patent Bulletin

Issue number:
202114
Publication date:
07/04/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages